Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for CDXS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 32.96M
March 31, 2026 43.23M
December 31, 2025 50.53M
September 30, 2025 38.54M
June 30, 2025 55.63M
March 31, 2025 49.63M
December 31, 2024 66.93M
September 30, 2024 73.40M
June 30, 2024 61.45M
March 31, 2024 79.27M
December 31, 2023 86.62M
September 30, 2023 91.51M
June 30, 2023 124.13M
March 31, 2023 126.02M
December 31, 2022 144.80M
September 30, 2022 154.13M
June 30, 2022 159.46M
March 31, 2022 158.64M
December 31, 2021 164.39M
September 30, 2021 169.06M
June 30, 2021 162.77M
March 31, 2021 163.74M
December 31, 2020 170.10M
September 30, 2020 90.80M
June 30, 2020 94.79M
Date Value
March 31, 2020 99.07M
December 31, 2019 105.52M
September 30, 2019 102.51M
June 30, 2019 98.68M
March 31, 2019 51.21M
December 31, 2018 56.31M
September 30, 2018 54.77M
June 30, 2018 52.53M
March 31, 2018 15.07M
December 31, 2017 24.55M
September 30, 2017 22.09M
June 30, 2017 30.64M
March 31, 2017 11.68M
December 31, 2016 19.10M
September 30, 2016 22.84M
June 30, 2016 19.68M
March 31, 2016 16.11M
December 31, 2015 22.88M
September 30, 2015 23.31M
June 30, 2015 17.10M
March 31, 2015 21.62M
December 31, 2014 26.31M
September 30, 2014 25.21M
June 30, 2014 29.33M
March 31, 2014 36.57M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 7.363B
Bio-Rad Laboratories, Inc. 7.174B
Bruker Corp. 2.381B
Azenta, Inc. 1.510B
Danaher Corp. 52.58B

Shareholders Equity (Quarterly) Related Metrics